Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I and II Study of NovoTTF-200A and Pembrolizumab in Newly Diagnosed Melanoma Brain Metastasis

NCT04129515 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT04129515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04129515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I and II Study of NovoTTF-200A and Pembrolizumab in Newly Diagnosed Melanoma Brain Metastasis
Lead sponsor
Brown University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
October 30, 2025
Completion date
January 31, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma brain metastasis, metastatic melanoma